Close Menu

Lynntech

The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.

A former scientist from Texas-based R&D firm Lynntech who was developing a nucleic acid sample prep module intended for use with molecular diagnostic assays for resource-poor areas of the world has left the company and founded his own startup to commercialize an improved vers

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.